Bharat Pharma (a Unit Of Bharat Explosives Ltd), based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DILUTED NITROGLYCERIN USP, with a corresponding US DMF Number 27609.
Remarkably, this DMF maintains an Active status since its submission on October 24, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 12, 2014, and payment made on October 28, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II